Last deal

$20M

Amount

Series A

Stage

04.10.2022

Date

2

all rounds

$20M

Total amount

date founded

Financing round

General

About Company
Biopharmaceutical Research Company develops active pharmaceutical ingredients for plant therapeutics.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2017

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company specializes in producing cannabis for researchers in the US and THC testing of hemp that complies with USDA regulations. Their services include analyzing hemp and cannabis for potency, contaminants, and stability data generation. They aim to provide high-quality, federally compliant pharmaceutical ingredients and plant-based therapeutics for patients and researchers to find treatments for post-traumatic stress disorder, chronic pain, and other ailments. BRC is a pharmaceutical manufacturing and development firm that produces DEA-approved cannabinoid API and botanically derived therapeutics.
Contacts
Similar Companies
1000
Benuvia

Benuvia

Benuvia Therapeutics Inc. is a pharmaceutical company focused on developing and commercializing therapies for rare diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Round Rock, TX, USA
GW Pharmaceuticals

GW Pharmaceuticals

GW Pharmaceuticals is a biopharmaceutical company developing and commercializing therapeutics derived from cannabinoids.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Histon, Cambridge, UK

total rounds

6

total raised

$1.22B
Zynerba Pharmaceuticals

Zynerba Pharmaceuticals

Zynerba is a clinical-stage pharmaceutical company that develops cannabinoid treatments for rare neurological diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Devon, PA, USA

total rounds

2

total raised

$13M
Kala Pharmaceuticals Boston

Kala Pharmaceuticals Boston

Kala Pharmaceuticals is a clinical-stage biopharmaceutical company developing innovative therapies for rare eye diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Boston, MA, USA

Financials

Funding Rounds
2
2

Number of Funding Rounds

$20M

Money Raised

Their latest funding was raised on 04.10.2022. Their latest investor Atacama Ventures. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
01.01.2019
1
Intrinsic Capital Partners

Intrinsic Capital Partners

Intrinsic Capital Partners is an investment firm focused on the emerging legal cannabis industry.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Cannabis, Financial Services, Venture Capital

Location

Philadelphia, PA, USA

count Of Investments

8
Co-Investors
Investors
7
1

Number of lead investors

7

Number of investors

Investor 
Lead 
Round 
Partners 
Atacama Ventures

Atacama Ventures

Atacama Ventures is a San Francisco-based early-stage venture fund that invests in technology companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Financial Services, Finance

Location

San Francisco, CA, USA

count Of Investments

9
Intrinsic Capital Partners

Intrinsic Capital Partners

Intrinsic Capital Partners is an investment firm focused on the emerging legal cannabis industry.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Cannabis, Financial Services, Venture Capital

Location

Philadelphia, PA, USA

count Of Investments

8
Howard Goodwin

Howard Goodwin

Howard Goodwin is the Partner and Founder of Intrinsic Capital Partners. Howard Goodwin attended the Thomas Jefferson University.

current job

Intrinsic Capital Partners
Intrinsic Capital Partners
Delta Emerald Ventures

Delta Emerald Ventures

This company invests in cannabis businesses, talent, and technology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Cannabis Producers

Keywords

Venture Capital, Financial Services, Cannabis

Location

New York, NY, USA

count Of Investments

15

People

Employee Profiles
1
Lee Mannion

Lee Mannion

Director of Business Development

Activity

Recent News
0